SwipeRx is equipping pharmacies in Southeast Asia to advance patient care and transform global health. Impact Ventures provided SwipeRx tailored pro bono services from J&J employees, which has proven instrumental in shaping the company’s future.

In 2023, Impact Ventures by J&J Foundation invested in Penda Health to support and expand access to trustworthy, high-quality healthcare to communities in Kenya. Impact Ventures’ essential support included providing Penda Health with pro bono services from Johnson & Johnson employees with expertise and insights.

Since 2019, Impact Ventures by J&J Foundation has invested in companies developing innovative solutions to improve access to quality and affordable healthcare. We have also helped to build an ecosystem where early-stage health impact innovation can thrive by supporting entrepreneurs, pitch competitions, accelerator programs, research and advocacy. Though we are focused on our mission to catalyze more impact in the future, we reflect back on highlights from the last five years.

Pioneering a transformative model for emerging markets’ healthcare access, reach52 is a social impact business that leverages technology, local health networks, supply chain and public health strategies to deliver health in rural and hard-to-reach areas. reach52 is bridging the gap where traditional healthcare systems often fall short.